Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial

Name: Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial
License: Public Domain

University of Southern California

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent plasma cell myeloma, refractory plasma cell myeloma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 148745
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.